| 000 | 01329 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513201205.0 | ||
| 264 | 0 | _c20000124 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNash, M A | |
| 245 | 0 | 0 |
_aIn vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin. _h[electronic resource] |
| 260 |
_bCancer research _cDec 1999 |
||
| 300 |
_a6192-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarboplatin _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 |
_aCyclins _xmetabolism |
| 650 | 0 | 4 | _aDecorin |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aExtracellular Matrix Proteins |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGrowth Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProteoglycans _xpharmacology |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aLoercher, A E | |
| 700 | 1 | _aFreedman, R S | |
| 773 | 0 |
_tCancer research _gvol. 59 _gno. 24 _gp. 6192-6 |
|
| 999 |
_c10582285 _d10582285 |
||